Sirius Investors
23.99
0.04%Today
Market Cap
5.52B
Volume
7.43M
52W High
25.32
52W Low
12.48

No historical price data available

No price history data available for the selected time period.

Try selecting a different time range.

Company Overview

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.

Company Information

CEO
Alan Thomas Hirzel BS,
Sector
Healthcare
Industry
Biotechnology
Employees
1760

Contact Information

Address
Discovery Drive
Country
GB